Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Other Non-Current Assets (2017 - 2025)

Q32 Bio (QTTB) has 9 years of Other Non-Current Assets data on record, last reported at $647000.0 in Q3 2025.

  • For Q3 2025, Other Non-Current Assets changed N/A year-over-year to $647000.0; the TTM value through Sep 2025 reached $647000.0, changed N/A, while the annual FY2024 figure was $647000.0, 2713.04% up from the prior year.
  • Other Non-Current Assets reached $647000.0 in Q3 2025 per QTTB's latest filing, up from $570000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $5.6 million in Q1 2023 and bottomed at $23000.0 in Q4 2023.
  • Average Other Non-Current Assets over 5 years is $1.7 million, with a median of $1.3 million recorded in 2021.
  • Peak YoY movement for Other Non-Current Assets: tumbled 78.34% in 2022, then surged 2713.04% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $2.0 million in 2021, then plummeted by 85.87% to $276000.0 in 2022, then tumbled by 91.67% to $23000.0 in 2023, then soared by 2713.04% to $647000.0 in 2024, then changed by 0.0% to $647000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Assets were $647000.0 in Q3 2025, $570000.0 in Q2 2025, and $647000.0 in Q4 2024.